Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

A new method to detect ribonucleic acid (RNA) without needing any complex lab procedures or heating equipment has been ...

He had advocated for unproven Covid-19 treatments like hydroxychloroquine during the Covid-19 pandemic. Read more at ...

As we enter entrepreneurship month this November, we’re celebrating the professors and alumni who are fueling job creation ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

The collaboration will utilise Lundbeck's neuroscience experience and Contera Pharma's oligonucleotide expertise.

Novartis is buying Avidity Biosciences in an all-cash deal valued at $12 billion to access Avidity's experimental treatments for neuromuscular diseases.

Jonathan Henninger, an assistant professor of biological sciences, is part of a growing movement in the life sciences exploring how ribonucleic acid, known as RNA, can be harnessed to develop ...